Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.10.31
关于重大资产重组事项的进展公告
2013.10.29
关于2013年第三季度报告的更正公告
2013.10.28
第二届董事会第二十八次会议决议公告
2013.10.28
关于向银行申请专项授信额度的公告
2013.10.25
关于重大资产重组事项的进展公告
2013.10.21
关于重大资产重组事项的进展公告
2013.10.15
关于重大资产重组事项的进展公告
2013.10.10
关于部分产品生产停产的公告
2013.10.09
关于筹划重大资产重组的停牌公告
2013.10.09
第二届董事会第二十七次会议决议公告
第一页
上一页
123
124
125
126
127
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
